We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.22B
AUM Growth
+$2.7B
Cap. Flow
+$3.76B
Cap. Flow %
89.24%
Top 10 Hldgs %
40.53%
Holding
623
New
593
Increased
5
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
OSH
Oak Street Health, Inc.
OSH
+$211M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$189M
3
UNVR
Univar Solutions Inc.
UNVR
+$175M
4
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$143M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$137M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$196M
2
SGFY
Signify Health, Inc.
SGFY
+$161M
3
ONEM
1Life Healthcare
ONEM
+$141M
4
TGNA
TEGNA Inc
TGNA
+$46.6M

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.36%
3 Technology 18.59%
4 Industrials 5.57%
5 Real Estate 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCYC
326
Bicycle Therapeutics
BCYC
$287M
$1.72M 0.04%
+80,719
New +$2.02M
HHLA
327
DELISTED
HH&L Acquisition Co.
HHLA
$1.71M 0.04%
+165,984
New +$1.69M
ALGN icon
328
Align Technology
ALGN
$12.2B
$1.71M 0.04%
+5,125
New +$1.51M
ATRC icon
329
AtriCure
ATRC
$2.08B
$1.71M 0.04%
+41,160
New +$1.71M
STAA icon
330
STAAR Surgical
STAA
$1.17B
$1.7M 0.04%
+26,615
New +$1.74M
RAPT
331
DELISTED
RAPT Therapeutics
RAPT
$1.69M 0.04%
+11,506
New +$2.33M
LEN.B icon
332
Lennar Class B
LEN.B
$20.7B
$1.67M 0.04%
+19,669
New +$1.56M
SKIL icon
333
Skillsoft
SKIL
$76M
$1.67M 0.04%
+41,682
New +$1.49M
BRIV
334
DELISTED
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
$1.66M 0.04%
+163,565
New +$1.65M
SKYA
335
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
$1.64M 0.04%
+160,410
New +$1.63M
CORS
336
DELISTED
Corsair Partnering Corporation
CORS
$1.63M 0.04%
+158,743
New +$1.61M
VRDN icon
337
Viridian Therapeutics
VRDN
$2.59B
$1.62M 0.04%
+63,543
New +$2.04M
NTAP icon
338
NetApp
NTAP
$37.1B
$1.6M 0.04%
+25,000
New +$1.61M
IQV icon
339
IQVIA
IQV
$38.8B
$1.59M 0.04%
+8,019
New +$1.71M
LKFT
340
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.76B
$1.59M 0.04%
+41,250
New +$1.7M
ADPT icon
341
Adaptive Biotechnologies
ADPT
$3.89B
$1.58M 0.04%
+178,586
New +$1.57M
VTYX
342
DELISTED
Ventyx Biosciences
VTYX
$1.58M 0.04%
+47,026
New +$1.83M
CXM icon
343
Sprinklr
CXM
$1.61B
$1.56M 0.04%
+120,362
New +$1.22M
SILK
344
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1.54M 0.04%
+39,482
New +$1.93M
GTM
345
ZoomInfo Technologies
GTM
$1.22B
$1.54M 0.04%
+62,500
New +$1.6M
QURE icon
346
uniQure
QURE
$3.2B
$1.51M 0.04%
+75,075
New +$1.58M
AONC
347
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$1.5M 0.04%
+145,540
New +$1.48M
AGNC icon
348
AGNC Investment
AGNC
$12.9B
$1.48M 0.04%
+146,952
New +$1.6M
HCP
349
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$1.48M 0.04%
+50,537
New +$1.51M
GSQB
350
DELISTED
G Squared Ascend II Inc.
GSQB
$1.47M 0.03%
+141,786
New +$1.45M
12 13
14
15 16

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 623 positions worth $4.22B, up 177% from $1.52B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor deployed $3.76B of net new capital in Q1 2023, opening 593 new positions and adding to 5 existing holdings. Its largest new stake was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Activision Blizzard, an estimated $196M trimmed.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited Signify Health, Inc. in Q1 2023, selling an estimated $161M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 593 new positions and closed 3 in Q1 2023.
  • UBS O'Connor's portfolio value rose 177% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.